Search research articles
Contact Us
Filters
Showing results (21-30 of 229) with videos related to
Page
of 23
Sort By:
Cancer Chemotherapy and Pharmacology
|
November 21, 2007
Safety and anti-tumor activity of sorafenib (Nexavar) in combination with other anti-cancer agents: a review of clinical trials
Chris H Takimoto, Ahmad Awada
Hematology/Oncology Clinics of North America
|
January 7, 2003
Heat shock protein and proteasome targeting agents
Chris H Takimoto, Shrinivas Diggikar
Southern Medical Journal
|
February 27, 2003
Pineal germinoma followed by hematogenous metastases
Muhammad Wasif Saif, Chris H Takimoto
Sapporo Igaku Zasshi. the Sapporo Medical Journal
|
November 1, 1970
[An epidermal tumor regarded as an eccrine porocarcinoma spreading wtih the pattern of so-called intraepidermal epitheliomas]
Y Fuse, T Iwasaki, H Takimoto
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 2003
Dose-intense paclitaxel: deja vu all over again?
Chris H Takimoto, Eric K Rowinsky
Journal for Immunotherapy of Cancer
|
May 9, 2025
Oncolytic viruses targeting CD47: a new road to success?
Chris H Takimoto, Michael J Wick
Consultant
|
April 22, 2022
Macroglossia in a Patient With Recurrent Multiple Myeloma
Muhammad Wasif Saif, Chris H Takimoto
Seminars in Hematology
|
October 21, 1998
An overview of topoisomerase I-targeting agents
S G Arbuck, C H Takimoto
Journal of the American Chemical Society
|
December 20, 2011
Gas-phase hydration reactions of protonated alcohols. Energetics and bulk hydration of cluster ions
K Hiraoka, H Takimoto, K Morise
Applied Neurophysiology
|
January 1, 1979
Effects of substantia nigra upon cortical photic evoked responses [proceedings]
K Koshino, H Mogami, H Takimoto
Page
of 23
Search research articles
Search
Showing results (21-30 of 229) with videos related to
Sort By:
Page
of 23
Cancer Chemotherapy and Pharmacology
|
November 21, 2007
Safety and anti-tumor activity of sorafenib (Nexavar) in combination with other anti-cancer agents: a review of clinical trials
Chris H Takimoto, Ahmad Awada
Hematology/Oncology Clinics of North America
|
January 7, 2003
Heat shock protein and proteasome targeting agents
Chris H Takimoto, Shrinivas Diggikar
Southern Medical Journal
|
February 27, 2003
Pineal germinoma followed by hematogenous metastases
Muhammad Wasif Saif, Chris H Takimoto
Sapporo Igaku Zasshi. the Sapporo Medical Journal
|
November 1, 1970
[An epidermal tumor regarded as an eccrine porocarcinoma spreading wtih the pattern of so-called intraepidermal epitheliomas]
Y Fuse, T Iwasaki, H Takimoto
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 2003
Dose-intense paclitaxel: deja vu all over again?
Chris H Takimoto, Eric K Rowinsky
Journal for Immunotherapy of Cancer
|
May 9, 2025
Oncolytic viruses targeting CD47: a new road to success?
Chris H Takimoto, Michael J Wick
Consultant
|
April 22, 2022
Macroglossia in a Patient With Recurrent Multiple Myeloma
Muhammad Wasif Saif, Chris H Takimoto
Seminars in Hematology
|
October 21, 1998
An overview of topoisomerase I-targeting agents
S G Arbuck, C H Takimoto
Journal of the American Chemical Society
|
December 20, 2011
Gas-phase hydration reactions of protonated alcohols. Energetics and bulk hydration of cluster ions
K Hiraoka, H Takimoto, K Morise
Applied Neurophysiology
|
January 1, 1979
Effects of substantia nigra upon cortical photic evoked responses [proceedings]
K Koshino, H Mogami, H Takimoto
Page
of 23